B. Braun Executive and Leadership Team

Sri Sulistiowati, the Chief Financial Officer at B. Braun, directs financial strategy and oversight for key operational segments. This leadership involves managing fiscal planning, budgeting, and financial reporting to ensure robust economic health across the organization. Sulistiowati's role is critical in supporting B. Braun's global expansion and product development initiatives by providing sound financial guidance. The focus remains on optimizing resource allocation and driving profitability through disciplined financial management. Sri Sulistiowati ensures compliance with all financial regulations and standards, safeguarding the company's assets and stakeholder interests. This position requires a deep understanding of international financial markets and B. Braun's diverse business units, from infusion therapy to hospital pharmacy solutions.

Scott Farrell, the Group Chief Financial Officer at B. Braun, directs the overarching financial architecture and strategic fiscal planning for the entire global enterprise. This executive role encompasses managing consolidated financial statements, capital allocation, and investor relations, ensuring B. Braun's financial resilience and growth trajectory. Farrell's responsibilities include driving financial performance across all business units, from surgical instruments to dialysis solutions, and identifying opportunities for fiscal optimization. Scott Farrell works closely with divisional finance leaders to implement consistent financial policies and reporting standards worldwide. The strategic financial direction provided by Farrell supports B. Braun's long-term objectives and its commitment to delivering innovative healthcare solutions across more than 60 countries.

Edwin Omar, the Chief Financial Officer & Bbraun Medical Peru S A Board Member at B. Braun, leads financial operations and strategic fiscal management specifically for the Peruvian market, while also contributing to board-level governance. This dual role involves overseeing local financial planning, budgeting, and reporting, ensuring fiscal health and compliance within Peru. Omar's responsibilities extend to providing financial insights that support B. Braun's strategic objectives in the region, including the distribution of medical devices and pharmaceutical solutions. Edwin Omar's position on the Bbraun Medical Peru S A Board allows for direct influence on regional business strategy and operational decisions. The financial acumen applied by Omar is crucial for driving sustainable growth and operational efficiency in the Peruvian healthcare sector.

Muhammad Arqam, the Head Chief Financial Officer, Strategic Accounts Management at B. Braun, spearheads financial strategy and oversight for critical strategic accounts, ensuring their fiscal alignment and profitability. This specialized role focuses on managing the financial aspects of key partnerships and large-scale contracts, optimizing revenue streams and cost structures for these significant relationships. Arqam's leadership ensures that financial planning and analysis directly support the success of B. Braun's strategic account initiatives, particularly in areas like infusion therapy and hospital pharmacy solutions. Muhammad Arqam collaborates closely with sales and business development teams to drive financial performance and secure long-term value from these vital partnerships. The financial expertise provided by Arqam is essential for maintaining B. Braun's competitive edge in managing its most important client relationships.

Cristian Vacarezza, the Principal Chief Financial Officer at B. Braun, provides high-level financial guidance and strategic direction across significant operational domains. This executive function involves deep analysis of financial performance, risk assessment, and the development of fiscal strategies to support B. Braun's overarching business objectives. Vacarezza's role is instrumental in shaping financial policies and ensuring robust financial controls are in place to manage the company's extensive portfolio, which includes dialysis and wound care solutions. Cristian Vacarezza collaborates with various departments to drive financial accountability and optimize resource allocation, contributing to the company's sustained growth and market leadership. The financial expertise of Vacarezza underpins critical decision-making processes.

Willem deGoede, the Chief Operating Officer at B. Braun, oversees the execution of operational strategies across the company's global manufacturing and service delivery networks. This involves optimizing production processes, supply chain management, and ensuring the efficient delivery of B. Braun's extensive portfolio of medical devices and pharmaceuticals. DeGoede's leadership drives operational excellence, focusing on enhancing productivity and reducing costs while maintaining the highest quality standards essential for medical products. Willem deGoede collaborates with regional leaders to align operational capabilities with market demands, ensuring B. Braun's ability to serve healthcare providers effectively in areas like infusion therapy, wound care, and dialysis. The operational framework managed by deGoede supports B. Braun's mission to protect and improve patient health worldwide.

Andres Cepeda, the Director, Operations Colombia & Chief Operating Officer, Ecuador, Venezuela at B. Braun, directs operational execution and strategic oversight across multiple South American markets. This leadership position involves managing the end-to-end operational processes, including supply chain logistics, manufacturing coordination, and service delivery for B. Braun's diverse product lines in Colombia, Ecuador, and Venezuela. Cepeda's focus is on driving operational efficiency, ensuring product availability, and maintaining high-quality standards in these key regions. Andres Cepeda works to align regional operations with global B. Braun objectives, adapting strategies to meet local market needs for medical devices and pharmaceuticals. The operational leadership provided by Cepeda is vital for B. Braun's presence and growth in the Latin American healthcare landscape.

Chee Hong, the President, Asia Pacific at B. Braun, leads the strategic direction and operational oversight for the company across the diverse Asia Pacific region. This executive role involves driving market growth, managing regional business development, and ensuring the effective deployment of B. Braun's extensive medical device and pharmaceutical offerings. Hong's leadership focuses on adapting global strategies to meet the specific needs of healthcare markets throughout Asia Pacific, fostering strong relationships with local partners and customers. Chee Hong oversees the performance of B. Braun's operations in this critical growth area, ensuring alignment with the company's mission to protect and improve patient health. The regional leadership provided by Hong is essential for B. Braun's success and expansion in the dynamic Asia Pacific healthcare landscape.

Paul Alderete, the Chief Administrative Officer at B. Braun, oversees the critical administrative functions that support the company's global operations and strategic initiatives. This role encompasses managing essential corporate services, ensuring efficient internal processes, and optimizing resource utilization across various departments. Alderete's leadership focuses on enhancing organizational effectiveness and providing a stable operational framework that enables B. Braun to deliver its broad range of medical devices and pharmaceutical solutions. Paul Alderete works to streamline administrative procedures, implement best practices, and foster a productive work environment conducive to innovation and growth. The administrative oversight provided by Alderete is fundamental to the smooth functioning of B. Braun's extensive global network.

Mor Vamos, the Chief Operations Officer at B. Braun, directs the strategic execution of operational plans across the company's global network, ensuring efficiency and quality in product delivery. This leadership role involves optimizing manufacturing processes, supply chain management, and logistical operations for B. Braun's comprehensive medical product portfolio, including infusion therapy and surgical instruments. Vamos's focus is on driving operational excellence, enhancing productivity, and maintaining the highest standards of quality and safety. Mor Vamos collaborates with regional operational leaders to align global strategies with local market demands, ensuring B. Braun's capacity to serve healthcare providers effectively. The operational framework managed by Vamos is key to B. Braun's mission of improving patient health worldwide.